![ma gov hrd ma gov hrd](https://i1.rgstatic.net/publication/251341628_Systems_Theory_and_Thinking_as_a_Foundational_Theory_in_Human_Resource_Development_A_Myth_or_Reality/links/5e88485d299bf1307978930d/largepreview.png)
Dr Moore reported receiving fees from AstraZeneca, Clovis Oncology, TESARO, Genentech/Roche, ImmunoGen, Inc, Merck & Co, VBL Therapeutics, Janssen Pharmaceuticals, and OncoMed Pharmaceuticals, Inc.
![ma gov hrd ma gov hrd](https://www.macomptroller.org/wp-content/uploads/img_sidebar_forms-970x600.jpg)
Dr Matulonis reported serving in consulting/advisory roles for Merck KGaA, Clovis Oncology, Geneos Therapeutics, Eli Lilly and Company, and 2X Oncology. Dr Penson reported serving on scientific advisory boards for Merck & Co and TESARO. Dr Colon-Otero reported receiving research funding from Novartis.
MA GOV HRD TRIAL
Dr Sachdev reported receiving research funding from Celgene and Pfizer advisory board honoraria from Celgene and TapImmune, Inc drug-only support for an investigator-sponsored trial from Genentech and travel support from Celgene. Dr Holloway reported serving on a speaker bureau for TESARO. Dr Vidal reported consulting for Pfizer and Eli Lilly and Company and received research funding from Eli Lilly and Company, Genentech, AstraZeneca, Merck Serono, TESARO, Puma Biotechnology, and Bristol-Myers Squibb.
![ma gov hrd ma gov hrd](https://massgaming.com/wp-content/uploads/January-2021-Header.jpg)
Supervision: Konstantinopoulos, Moroney, Sachdev, Colon-Otero, Matulonis, Moore, Wang, Dezube, Munster.Ĭonflict of Interest Disclosures: Dr Konstantinopoulos reported serving on advisory boards for AstraZeneca, Pfizer, and Merck & Co. Obtained funding: D'Andrea, Bobilev, Dezube.Īdministrative, technical, or material support: Konstantinopoulos, Waggoner, Mita, Moroney, Penson, Matulonis, Swisher, Färkkilä, Wang, Buerstatte, Graham, Bobilev, Dezube. Statistical analysis: Wang, Arora, Dezube.
MA GOV HRD FULL
Konstantinopoulos, MD, PhD, Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, YC Room 1424, Boston, MA 02215 ( Contributions: Dr Konstantinopoulos and Ms Arora had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.Ĭoncept and design: Konstantinopoulos, Sachdev, Matulonis, Swisher, Wang, Arora, Bobilev, Dezube, Munster.Īcquisition, analysis, or interpretation of data: Konstantinopoulos, Waggoner, Vidal, Mita, Moroney, Holloway, Van Le, Sachdev, Chapman-Davis, Colon-Otero, Penson, Matulonis, Kim, Moore, Swisher, Färkkilä, D'Andrea, Stringer-Reasor, Wang, Buerstatte, Arora, Graham, Munster.ĭrafting of the manuscript: Konstantinopoulos, Colon-Otero, Swisher, D'Andrea, Graham, Dezube, Munster.Ĭritical revision of the manuscript for important intellectual content: Konstantinopoulos, Waggoner, Vidal, Mita, Moroney, Holloway, Van Le, Sachdev, Chapman-Davis, Colon-Otero, Penson, Matulonis, Kim, Moore, Swisher, Färkkilä, Stringer-Reasor, Wang, Buerstatte, Arora, Graham, Bobilev, Dezube, Munster.